THE EFFECT OF QUALITY OF LIFE ON CARDIOMETABOLIC
RISK FACTORS IN POSTMENOPAUSAL WOMEN

By

Chavela Riotutar

A Thesis Presented to
The Faculty of Humboldt State University
In Partial Fulfillment of the Requirements for the Degree
Master of Science in Kinesiology

Committee Membership
Dr. Taylor Bloedon, Committee Chair and Graduate Program Coordinator
Dr. Jill Anderson, Committee Member
Dr. Kari Pilolla, Committee Member
Dr. Kimberly Perris, Committee Member

May 2021

ABSTRACT

THE EFFECT OF QUALITY OF LIFE ON CARDIOMETABOLIC
RISK FACTORS IN POSTMENOPAUSAL WOMEN
Chavela Riotutar

Background: The emergence of cardiometabolic (CMD) indicators for Metabolic
Syndrome (MetS) coincides with the decline in estrogen production during menopause
and substantially increases development of cardiovascular disease (CVD) in women.
Quality of life (QOL) encompasses physical, material, and social well-being. Research
reveals a correlation between low QOL scores and CMD disease. Menopause
significantly increases CMD risk, and may also lower QOL scores. Objective: To
investigate the relationship between QOL and CMD risk in postmenopausal women.
Method: Cisgender, postmenopausal women (age > 45 years) were recruited through
emails to complete the online survey. Data collection included demographics, physical
characteristics and activity level, sexual health, medical history, current conditions, and
QOL satisfaction level. Results: MetS indicators were present, symptoms of menopause
were prevalent, and QOL satisfaction was low. Discussion: QOL satisfaction is impacted
by the physiological changes of menopause and MetS conditions. Lifestyle modifications
during perimenopause are needed to improve health and reduce the risk of CMD disease.
Keywords: menopause, post-menopausal, quality of life, cardiometabolic indicators,
metabolic syndrome, covid-19
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1
INTRODUCTION

A major health hazard is growing in our modern world that is not a communicable
disease, rather a consequence of the Western lifestyle’s influence. Metabolic syndrome
(MetS) has become a global epidemic, resulting from increased consumption of high
calorie, low fiber, processed and ultra-processed foods, compounded by a decrease in
physical activity and more sedentary leisure time activities. The cluster of risk factors
known as MetS is characterized by the co-occurrence of at least three of the five
following criteria: elevated waistline circumference; elevated blood pressure; elevated
triglycerides; elevated fasting blood glucose level; and decreased level of HDL-C. The
combination of these conditions substantially increases the risk for development of Type
2 diabetes and cardiovascular disease (CVD) (Saklayen, 2018). Chronological aging is an
additional factor as the risk for stroke doubles with every decade after the age of 55
(CDC, 2017). In 2017, 12.2% of adults in the United States had Type 2 diabetes and 34%
had MetS (Saklayen, 2018). The economic impact of MetS is evidenced by the high
usage of medical care associated with the individual components of MetS, i.e., a 40%
increase in medical care costs after the incidence of diabetes, amounting to trillions
worldwide (Nichols & Moler, 2011). In a longitudinal, 9-year study by Janssen et al.
(2010), menopause-related testosterone levels were implicated as a hormonal change
associated with three of the five components of MetS due to the accumulation of
intraabdominal fat that contains more androgen receptors. The research suggests that a
decrease in estrogen levels, which promote gluteo-femoral fat accumulation, leads to the
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androgen-dominated hormonal milieu that increases a woman’s risk for MetS. Before the
age of 45, CVD is rare among women but after the age of 65, cardiometabolic risk factors
accelerate until they surpass those in men, demonstrating that menopause increases the
risk of CVD independent of normal aging (Ebtekar et al, 2018). The emergence of MetS
indicators during menopausal transition coincides with the decline in estrogen production
and may explain the higher rate of CVD in postmenopausal women (Carr, 2003). Due to
the hormonal changes of menopause, CVD is the primary cause of mortality for women
in the United States, responsible for about 1 in every 5 deaths in 2017 (CDC, 2020).
The gradual process leading to menopause begins around age 45 when fertility
declines as the ovaries get smaller and produce less of the hormones (estrogen and
progesterone) that control the menstrual cycle (Pinkerton & Stovall, 2010).
Perimenopause begins about three to five years before menopause and is characterized by
irregular menstrual cycles, vasomotor symptoms, and psychological reactions (Larroy et
al., 2020). Menopause is reached when a woman has no menstrual cycle for twelve
months without any other cause, (e.g., illness, medication), and post menopause is the
final stage, one year since the last menstrual cycle until end of life. The direct effect of
estrogen deficiency on body fat distribution (central obesity), insulin action, and
stiffening of the arterial wall increase the chance for a menopausal woman to develop
MetS by 60% (Carr, 2003). Identification and treatment of these indicators for MetS at an
early stage provides the opportunity to prevent or postpone diabetes and CVD by making
changes to daily lifestyle. Modifications to physical activity and diet may reduce future
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health care needs and improve overall well-being and quality of life (QOL) during
menopause.
The significance of QOL as a public health concern was established by the World
Health Organization (WHO) in 1949; health is not just an absence of disease, it is a state
of complete physical, mental, and social well-being determined by: personal habits, social
engagement, education/income, and living environment, (WHO, 2019). A healthy living
environment is associated with a lower incidence of diabetes and hypertension while
adverse living conditions increase the production of cortisol and the risk for CVD, (Diez
Roux et al., 2016). Transitioning into menopause has been found to have a consistently
negative impact on QOL, health outcomes, and increased health risks. However, research
surrounding this topic fails to address several important variables associated with a
woman’s physiological aging process such as changes in sexual activity, alterations in
sleep patterns, increased caregiving responsibilities, and severity of chronic medical
conditions that occur during menopause (Hess et al., 2012). The current life expectancy
of women in the United States is 81.1 years (CDC, 2020). Accordingly, it can be said that
women who live 81 years spend a significant part of their life in post-menopausal status.
Menopause and MetS are both associated with an unsatisfactory QOL in several studies
linking social factors to health. By considering all domains that impact postmenopausal
health, we can better understand how to assist this population to enhance QOL and
improve health outcomes.
Research demonstrates a correlation between low QOL scores and increased risk
for cardiometabolic diseases. Additionally, menopause has been correlated with lower
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QOL scores as well as increased risk for cardiometabolic diseases. The direct connection
between these three conditions has yet to be examined. Therefore, the purpose of this
study is to investigate the relationship between QOL and cardiometabolic risk indicators
in postmenopausal women. The objective of this study is to assess the impact of
menopause on QOL and the associated risk factors of cardiometabolic disease,
specifically metabolic syndrome in postmenopausal women. Hypothesis: Postmenopausal
women that express a greater burden in life (stress, financial struggle, social isolation,
etc.) will show greater signs of negative cardiometabolic health outcomes.
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REVIEW OF LITERATURE

The following review of literature will cover cardiometabolic risk factors,
physiological changes during menopause, the increased health risks during menopausal
transition and the impact of menopause on QOL.
Cardiometabolic Risk Factors and Metabolic Syndrome
Metabolic syndrome is a cluster of cardiometabolic risk factors that substantially
increase the development of cardiovascular disease (CVD). A diagnosis of MetS occurs
when any three of the five following criteria are present: (1) elevated waist circumference
( ³ 35 inches for women; ³ 40 inches for males); (2) elevated triglycerides (³150 mg per
100 ml); (3) elevated blood pressure (³130/³ 85 mm Hg); (4) elevated fasting glucose (
³110 mg per 100 ml); and (5) decreased HDL-C (<50 mg per 100 ml for women; <40 mg
per 100 ml for men) (Vetter et al., 2011). A combination of these disorders increases the
risk for development of CVD greater than the presence of any one condition alone (Gurka
et al., 2016). All of the defining risk factors in MetS are associated with increased annual
medical costs, and expenses are magnified by each component resulting in higher future
medical costs (Nichols & Moler, 2011). Researchers at the University of Washington
School of Medicine found that the cost for healthcare in the United States was $2.7
trillion dollars in 2016, and 27% of that cost was attributed to modifiable risk factors
associated with cardiometabolic disease, such as obesity and smoking. The expense of
treating obesity was $238.5 billion, hypertension treatment expense was $179.9 billion,
and the cost for treatment of high fasting plasma glucose was $171.9 billion (Dieleman et
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al., 2020). Healthcare spending continues to increase and 18% of the United States
economy is currently directed towards healthcare expenses. Unmanaged risk factors are
not only costly but may result in the prevalence of associated co-morbidities if left
untreated (Dieleman et al., 2020). The five conditions that contribute to the risk for
development of MetS are linked, and abdominal obesity’s contribution is significant as it
leads to increased insulin resistance, the common denominator for the risk of MetS
development (Paley & Johnson, 2018). Figure 1 illustrates the link between components.

Lifestyle
Genetics

Dyslipidemia

Obesity

MetS

Adipocytokines
Inflammatory Factors

Insulin Resistance
Inflammation

Hypertension

DM2
Endothelial Dysfunction

CVD

Atherosclerosis

Figure 1. Relationship between MetS components and cardiometabolic indicators
Fat deposits increase with age as a result of the changing hormonal environment,
more sedentary leisure time activities, high calorie eating habits, changes in lean mass,
and lack of physical activity. It is estimated that adults spend eight to ten hours per day
engaged in sedentary behaviors that involve sitting, (e.g., using a computer, smartphone
apps, television viewing, time spent in vehicles) due to societal trends that move toward
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urbanization, mechanization and technological advancements (Vincent et al., 2017). The
body’s preference for fat storage shifts from the periphery, i.e., face, arms, and legs, to
the central abdominal region, especially the viscera. The role of visceral obesity in the
development of insulin resistance and MetS has been associated with a higher risk for
diabetes, and central adiposity is the most predominantly used diagnostic criteria for
MetS (Paley & Johnson, 2018). Adipocytes are metabolically active, secreting over a
dozen hormones affecting appetite, satiety, and energy metabolism of the body
(Saklayen, 2018). Excessive visceral fat deposits are associated with the development of
adipose cells that are enlarged, dysfunctional, and secrete pro-inflammatory biomarkers
including prostaglandins, C-reactive protein (CRP), and cytokines. A high body fat
percentage contributes to the dysfunction by signaling the release of inflammatory
mediators from adipose tissue that increase the circulation of free fatty acids requiring
greater insulin secretion for control of glucose metabolism. The resulting
hyperinsulinemia desensitizes insulin-sensitive tissues, which predisposes individuals to
type II diabetes (Paley & Johnson, 2018). Increased visceral fat accumulation and insulin
resistance are two of the most important pathophysiological components of MetS and are
associated with increased future healthcare needs and expenses (Stefanska et al., 2015).
Menopause
The clinical diagnosis for menopause is 12 consecutive months of amenorrhea
after a woman’s final menstrual period, signifying the end of her reproductive stage. The
human ovary contains a finite number of non-growing follicles established in utero that
decline with age. This decline of ovarian function results in a reduction of estrogen
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secretion with a shift towards androgen dominance, culminating in menopause around
age 50 (Wallace & Kelsey, 2010). Menopause is not a single climacteric event, it is a
transition between the reproductive phase and the non-reproductive phase that may span
over a decade depending on the individual (Soules et al., 2001). The identification of
phases was established by The Stages of Reproductive Aging Workshop (STRAW), and
is based on the characteristics of the menstrual cycle, supportive criteria (endocrine
biomarkers and antral follicle count (AFC)), and descriptive characteristics (e.g.,
vasomotor symptoms). This criteria divides a woman’s life into three phases;
reproductive, menopause transition, and post menopause (Stefanska et al., 2015). The
first signs of impending menopause begin in the later years of the reproductive phase,
also referred to as perimenopause. This phase is characterized by variable lengths of the
menstrual cycle with a shorter duration of the follicular stage and increased anovulatory
cycles. The perimenopause phase varies in length for each woman with menstrual
irregularities that may span four to six years before the final menses (Carr, 2003). During
the perimenopausal phase, the diminishing activity of the ovaries is a catalyst for changes
in hormone levels that result in physiological symptoms affecting the physical,
vasomotor, psychosocial, and sexual domains (Pinkerton & Stovall, 2010). The severity
and duration of physiological symptoms are unique for each woman and may impact their
personal and social performance leading to multiple serious issues in life and her sense of
purpose (Taebi et al., 2018). The end of perimenopause occurs after 12 months have
passed since the final menstrual period, and the phase of menopause begins. Post
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menopause has an early phase that lasts from five to eight years since the onset of
menopause and a late phase that continues until the time of death (Stefanska et al., 2015).
Physiological changes
During the transition through menopause, decreasing ovarian activity is associated
with physiological symptoms such as headache, sleep disorder, mood swings,
concentration deficits, hot flashes, anxiety, and vaginal dryness. The intensity, duration
and impact of these symptoms are as unique as the individual experiencing them.
Additionally, negative health outcomes such as osteoporosis are also linked to lower
levels of estrogen and connected to the activity of estrogen receptors in bone (Pinkerton
& Stovall, 2010). Please refer to Table 1 for a detailed list of menopausal symptoms from
the Menopause-Specific QOL (MENQOL) Questionnaire, Women’s Health Society,
Toronto, Canada.
Table 1. Physiological symptoms of menopause categorized by domain
Vasomotor
Hot Flushes
Night Sweats
Sweating

Psychological
Dissatisfaction with life
Feeling anxious, nervous
Poor Memory
Accomplishing less
Feeling depressed, down
Impatience with others
Willing to be alone

Physical
Flatulence or gas pain
Muscle or joint aches
Feeling tired, worn out
Difficulty sleeping
Ache in back, neck, head
Decreased physical strength
Decrease in stamina
Feeling a lack of energy
Skin dryness
Changes in skin tone, spots
Increased facial hair
Weight gain
Bloated feeling
Low backache
Frequent urination
Involuntary urination

Sexual
Changes in desire for sex
Vaginal dryness
Pain with intercourse
Avoiding intimacy
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The most common reason that women seek medical treatment during menopause
is hot flashes. It is not life threatening, but an unpleasant and painful experience triggered
by a reduction in estrogen levels. The hot flash begins with a sudden redness of skin on
the face, neck and chest with elevations in core body temperature, followed by
perspiration and feeling weak or dizzy (Bani et al., 2013). The reduction in estrogen
production increases the activity and stimulation of serotonin receptors (5-HT2A) in the
hypothalamus where the temperature regulation center triggers autonomic responses of
increased body temperature and extreme sweating, ending with shivering as the body
cools. Hot flashes usually last about one to five minutes, with lingering effects that can
decrease the quality of physical, emotional and social life (Bani et al., 2013).
Additionally, hot flashes affect sleep quality and higher rates of somatic, psychological,
and menopausal symptoms are seen in women with frequent vasomotor disturbances
(M.-J. Kim et al., 2018). Studies also show a higher rate of sleep disturbance during the
perimenopausal and postmenopausal phases, compared to the reproductive phase, and
that poor sleep quality increases the severity of physiological symptoms and risk for
negative health outcomes (M.-J. Kim et al., 2018).
Both menopause and normal aging contribute to a loss of muscle tone throughout
the body and is significant in regard to the pelvic floor which holds the uterus and bladder
in place above the vagina. Bladder control problems may develop with a weakened pelvic
floor and cause urinary leakage when sneezing or coughing. In severe cases, the lack of
muscle tone in the pelvic floor tissue allows the uterus, bladder, and bowel wall to sag
into the vagina or protrude outside of the vagina. This urogenital condition has
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repercussions beyond incontinence that may impact a woman’s personal life, social
performance, sense of well-being and may lead to future negative health outcomes (Taebi
et al., 2018).
Declining levels of estrogen related to natural menopause have an effect on sexual
interest, responsiveness and frequency in 50% of postmenopausal women (Pinkerton &
Stovall, 2010). Vaginal epithelium becomes thinner and more fragile due to decreases in
blood flow, resulting in decreased collagen and elastic fibers. The physical discomfort
due to vaginal dryness and pain with intercourse increases over the menopausal transition
and contributes to sexual dysfunction. A recent study by Arnot & Mace (2019) found that
sexual frequency is associated with the timing of menopause. If a woman is sexually
inactive, then pregnancy is impossible and there is no continued investment in the energy
required for ovulation. In their study, women who had sex monthly began menopause at a
later age. Women who are sexually active throughout menopause sustain their vaginal
health due to increased blood flow with sexual arousal, continued mechanical distention,
and possible seminal fluid benefits (Pinkerton & Stovall, 2010).
During the reproductive phase, estrogen promotes the accumulation of gluteofemoral fat, but the decline of estrogen with menopause is associated with an increase in
abdominal fat due to the dominance of androgens. This shift to central fat patterning
contributes to 400% more visceral fat in women between the third and seventh decades of
life, and is associated with insulin resistance, hyperinsulinemia, and dyslipidemia (Hunter
et al., 2010). The prevalence of weight gain in middle-aged women is increasing
worldwide; in 2018, two thirds of middle-aged women were overweight and one-third of
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them were obese. A combination of declining estrogen levels, environmental factors,
lifestyle and reduced physical activity contribute to weight gain during the menopausal
transition (Ebtekar et al., 2018). This is illustrated by Figure 2.
Menopause

Estrogen Decline

•
•
•

Androgen Increase

Body Composition Changes
Increased visceral abdominal fat, subcutaneous
abdominal fat, and ectopic fat storage
Decreased gluteo-femoral fat (peripheral)
Decreased total and peripheral lean body mass

Figure 2. The effect of hormonal changes in body composition with menopause
Dyslipidemia results from a combination of abdominal obesity, increased insulin
resistance, free fatty acid levels, and decreased adiponectin. These conditions contribute
through an increased secretion of particles containing apolipoprotein B. This leads to
hypertriglyceridemia and increased hepatic lipase activity resulting in a predominance of
small dense LDL particles and a reduction in large antiatherogenic HDL particles.
Metabolic changes in lipid profiles and elevated triglycerides after menopause increase a
woman’s risk for development of CVD and diabetes (Pinkerton & Stovall, 2010). During
perimenopause, lipid metabolism shifts toward a more atherogenic lipid profile similar to
MetS and may be related to the increase of visceral fat that emerges during the transition
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to menopause. However, further research is needed to understand what mechanisms are
underlying the menopausal changes that result in dyslipidemia (Carr, 2003).
Menopause and MetS

According to results from the Study of Women’s Health Across the Nation
(SWAN), menopause begins to increase the incidence of MetS six years before the final
menstrual period and continues to progress for another six years after menopause
(Janssen et al., 2008). The prevalence of MetS after menopause is estimated to be 31% to
55% globally, and three times higher among women in their postmenopausal phase
compared to women who were in their premenopausal phase (Stefanska et al., 2015). Due
to the increasing androgenicity of the hormonal environment during the transition,
menopause has been associated with insulin resistance, dyslipidemia, and diabetes
(Janssen et al., 2008). Menopause and the change in hormones are also associated with a
tendency for intraabdominal fat storage, a reduction in lean body mass, a lower resting
metabolic rate and less physical activity energy expenditure (Carr, 2003). Reduced
physical activity in combination with high calorie eating habits results in the reduction of
exercise capacity and contributes to a vicious cycle of muscle loss, inactivity, low
motivation and weight gain (Paley & Johnson, 2018).
Hypertension affects 25% of adult women worldwide with a higher prevalence in
women after the age of 60 (Pinto, 2007). The decline in estrogen concentration is the
mechanism potentially responsible for the increase in blood pressure, and is compounded
by chronological age and a proinflammatory state (Stefanska et al., 2015). Lower
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estrogen levels affect the elasticity of arterial walls and contribute to the development of
hypertension during the menopause transition (Stefanska et al., 2015).
The risk for dyslipidemia is linked to both aging and menopausal status through
different mechanisms related to abdominal obesity and insulin resistance. Additionally,
the hormonal change in the adipose tissue metabolism due to menopause exacerbates
these conditions leading to a higher risk for development of MetS in women (Stefanska et
al., 2015). The occurrence of MetS in postmenopausal women increases from 20% in the
fifth decade of life to 30% over the next ten years due to physiological changes and
lifestyle factors. It is important to consider that the life expectancy for women has
increased by 24 years since 1920, when the average age of death was only 57 (CDC,
2020). Women are living longer now and will spend about one third of their lives in the
postmenopausal phase. Changes to lifestyle and modifiable health risks are needed for the
prevention of cardiometabolic disorders and improved quality of life during a woman’s
transition through menopause (Ebtekar et al., 2018).
Quality of Life

Health is not just an absence of disease, it is a state of complete physical, mental,
and social well-being determined by our: personal habits, social engagement,
education/income, and living environment. This holistic state of being is known as
quality of life (QOL), the standard for a person’s health, comfort, and happiness. The
estimation of a sense of well-being can be assessed by the measurement of QOL (Larroy
et al., 2020). There are six broad domains of QOL established by the World Health
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Organization in 1949, (WHO); physical health, psychological health, level of
independence, social relations, environment, and personal spiritual beliefs. Each of the
six domains contains four facets, producing a questionnaire with a total of 100 items that
are rated on a five-point scale, then combined into one total score (WHOQOL-100.Pdf,
n.d.). This instrument is useful in clinical practice as a form of assessment to gather
valuable information in order for a practitioner to make informed choices for their patient
and improves the patient’s perception of their healthcare. Research and policymaking
utilize the QOL survey for insights into the nature of a disease by assessing the impact on
a patient’s well-being, and the effectiveness of different interventions (Burckhardt &
Anderson, 2003). Figure 2 illustrates the relationship between the domains of QOL.

Physical
Health
Living
Environment

Psychological
Health

Quality
of Life
Personal
Spiritual
Beliefs

Social
Engagement
Level of
Independence
Income

Figure 3. Domains of quality of life
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Menopause and quality of life
The decline of ovarian hormone production is associated with physiological
changes that may affect up to 80% of women during the menopause transition and
significantly affects her perception of QOL and individual purpose as a woman (Hess et
al., 2012). There is an expectation to remain youthful and attractive in certain cultures
while menopause signals aging and loss of attractiveness thus affecting the identity of
women (Larroy et al., 2020). Additionally, women who experience severe menopausal
symptoms are impacted in their personal and social functioning, resulting in a diminished
QOL and diminished sense of well-being (Taebi et al., 2018). Research by Kim & Cho,
(2020) documented that socioeconomic and social support contribute to the increased risk
of cardiometabolic disease in middle-aged women. They reported that women who are
more socioeconomically vulnerable have reduced accessibility to health care services
and are more prone to neglect their health due to work and family demands.
The role of women and family caregiving is an essential part of long-term
healthcare, with 66% of informal care providers being female. Caregivers are less likely
to have their own health needs met, have one or more chronic health conditions, along
with negative psychological and physical health outcomes associated with caregiving,
i.e., depression. The economic impact of caregiving responsibilities by women,
individually amounts to $142,693 in lost wages and $131,351 in lost Social Security
benefits as a result of early departure from the labor force, thereby affecting their
standard of living and QOL (Navaie-Waliser et al., 2002). In addition, Lidfeltdt et al.,
(2003) reported the importance of identifying non-biological risks that are linked to
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MetS, including low education and social isolation, but there is a lack of research
concerning women and menopause.
A longitudinal study of women’s health (STRIDE) conducted by the University of
Pittsburgh in 2011, demonstrated that the decrement in QOL associated with menopause
is most evident in overall physical health, frequency of pain, energy, and fatigue. The
emotional impact of menopause transition is more pronounced in the late perimenopausal
phase and early postmenopausal phases compared to late post menopause, indicating that
women are able to function in most aspects of life in spite of the physical discomfort of
symptoms (Hess et al., 2012). Evidence revealed by this review of literature demonstrates
the link between menopause and the cardiometabolic risk factors that lead to the
development of MetS. A woman’s risk for developing the MetS components of obesity,
insulin resistance, and hypertension is exacerbated by the physiological changes that
accompany menopause, and both MetS and menopause have been associated with an
unsatisfactory QOL that leads to negative health outcomes (Vetter et al., 2011).
The value of a scale for QOL is demonstrated by Vetter et al. (2011), who found
that MetS in itself is not associated with decreased QOL, but other factors such as
obesity, depression and greater disease burden may significantly influence QOL. Along
these lines, menopause was found to have a consistently negative impact on health related
QOL, irrespective of the symptoms. However, research surrounding it failed to address
several important variables associated with aging such as changes in sexual activity,
alterations in sleep patterns, increased caregiving responsibilities, and severity of chronic
medical conditions (Hess et al., 2012).
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The reliability of the survey as an instrument to measure QOL domains that are
conceptually distinct from other health status or causal indicators has been established by
previous research (Burckhardt & Anderson, 2003). The objective of this study is to
investigate the relationship between cardiometabolic health, the physiological changes of
menopause, and their impact on the domains of QOL.
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METHODS

Population and Sampling Procedures

The inclusion requirements for this study were cisgender women (age > 45 years)
with more than twelve months since the date of last menstruation (postmenopausal).
Additionally, all participants had internet access, and the ability to read and respond to
the confidential online survey in English. Participants were recruited through emails to
select women's groups with instructions and a link to the survey powered by
Qualtrics.com through Humboldt State University. Additionally, the researcher created
new social media pages on Facebook and Instagram specific to this study, and posted a
flyer with instructions and a link to the survey on Qualtrics.com. The survey was
administered by the participant in their own environment without a time constraint, and
responses were recorded on the Qualtrics.com secure website. Participants were excluded
if they did not complete the survey. Sampling was performed between December 2020
and March 2021. The Institutional Review Board of Humboldt State University (HSU)
granted approval for this research in 2020 (IRB registration #17-004).
Research Design

A non-experimental design with quantitative data was analyzed for correlation
between QOL and cardiometabolic health indicators in the postmenopausal phase.
Additionally, a multiple linear regression was performed to determine the relationship
between QOL scores and cardiometabolic risk indicators from the health history
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questionnaire using a statistical significance set at p < .05. There is no intervention or
control group. All participants were included in one group for this study.
Collection and Tabulation of Data

The statistical software G*Power 3.1 9.4 (Faul et al., 2009) was used to determine
the intended sample size of 64 postmenopausal women with a power of 0.80. There was a
total of 137 responses, which exceeded the required sample size. The primary measure is
the correlation between QOL and current health conditions; there are no secondary
measures. The QOL score was measured with 20 questions that assess the socioeconomic
factors identified as determinants of health: personal habits, social engagement,
education/income and living environment. The survey uses an 11-point response scale
ranging from extremely dissatisfied (0) to extremely satisfied (10), resulting in a total
score of 0 to 220 achieved by the sum of the responses. Please see Table 2 for
representative questions from each domain. Questions were compiled from the following
surveys: Perceived Quality of Life (Patrick et al., 1988), North American Menopause
Society (questionnaireNAMS.pdf, 1989 [MENQOL]), and Stanford Sleep Study
(stanfordhealthcare.org, 2020). These surveys have been proven to be reliable and
valid. Additional data collection included health history and the presence of metabolic
syndrome indicators, physical activity, sexual health, caregiving responsibilities, and
lifestyle. Given the timing of the survey, we included questions about changes due to the
impact of sheltering in place and social distancing measures instituted in March 2020.
The list of survey questions was shared with the researcher’s graduate committee for
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content, and construct validity to ensure they are valid instruments. The selected
questions for the QOL survey were reviewed and edited according to the committee’s
suggestions, and they were combined into this study’s QOL survey using Qualtrics
software (Qualtrics, Provo, UT). Representative questions are listed in Table 2.
Table 2. Representative Questions from each domain of QOL survey
QOL Subdomains

Representative Question

Living Environment

“Are you responsible for the care of someone else?
Partner? Parent? Child? Sibling? Grandchild?”

Social Engagement

“How dissatisfied or satisfied are you with how often you
see or talk to your family and friends?”

Personal Habits

“How dissatisfied or satisfied are you with how well
you care for yourself, for example, bathing, shopping, or
preparing meals?”

Income/Education

“In the past 12 months, how often were you unable to pay
the mortgage or rent on time?”

Analysis

The independent/predictor variables are five MetS risk indicators and the
dependent/outcome variable is the QOL total score, all classified as interval/ratio. IBM
SPSS Statistics 27 was used with a multiple linear regression model to analyze the
relationship between MetS indicators and QOL scores, with an alpha level set at p < .05,
and results are expressed as percentages, mean, and standard deviation. Data was
assessed for normality and no outliers were found. The assumption of independent errors
was not violated (Durbin-Watson = 2.146), VIF (< 10) and Tolerance (> 0.2) values
showed that multicollinearity was not problematic. The assumption of homoscedasticity
was not violated, shown by the normal ZRESID and ZPRED scatterplots.
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RESULTS

There was a total of 137 responses, of which 107 met the inclusion requirements
and completed the survey. The mean age of participants was 63 years, (± 8.7), ranging
from 54 to 72, and the mean years in postmenopause was 13.89, (± 9.9). Women (46%)
rated their overall health as good, 32% rated their overall health as average, 11% said
they had excellent overall health, and 11% said they had poor overall health. The
majority of participants (62%) had higher secondary and university education, and 38%
had some college. Almost half (45%) were retired, 23% were employed part-time, 21%
were employed full-time, and 10% had a disability. Socioeconomic data showed that 58%
had an annual income above $50,000, and 42% reported annual income less than
$49,000, please see Table 3.
Table 3. Sociodemographic characteristics of participants
Sociodemographic
Marital Status
Married
Living with Partner
Divorced
Separated
Widowed
Never Married
Ethnicity
White
Black or African American
American Indian or Alaska Native
Japanese
Guamanian or Chamorro
Mexican, Mexican-American, Chicana
Puerto Rican
Other Hispanic or Latino
Other
Employment

N

%

58
7
24
3
3
12

54
6
22
3
3
11

97
4
6
1
1
3
1
8
3

91
4
6
.9
.9
3
.9
7
2.8
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Sociodemographic
Working 35 or more hours per week
Working 34 or less hours per week
Unemployed or laid off
Retired
Disabled
Education
High school graduate
Some college
2-year degree
4-year degree
Professional degree
Doctorate
Annual Income
Less than $5000
$5000 to $11,999
$12,000 to $15,999
$16,000 to $24,999
$25,000 to $34,999
$35,000 to $49,000
$50,000 to $74,000
$75,000 to 99,000
$100,000 or greater

N
23
25
3
48
10

%
21
23
3
45
9

3
28
10
32
27
7

3
26
9
30
25
6

6
6
1
6
11
15
18
11
33

6
6
1
6
10
14
17
10
31

Note: Participants were on average 63.17 years old (SD = 8.71). Some participants checked multiple
ethnicities. Some were retired and working part-time.

The health history conditions were self-reported, and showed that a large number
of participants (n = 43) had waistlines above 35 inches (M = 43.85), blood pressure above
120/80mmHg (n = 37), elevated fasting glucose (n = 7), elevated triglycerides (n = 14),
low levels of high-density lipoprotein cholesterol (n = 6), and diabetes (n = 15). Table 4
shows the percentage of participants with the presence of metabolic syndrome indicators.
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Table 4. Participants with indicators for MetS
Self-reported conditions
Waistline > 35 in.
Hypertension > 120/80
Fasting Glucose >100mg/dL
TG > 150mg/dL
HDL-C < 50mg/dL
Type 1 Diabetes
Type 2 Diabetes

N

With conditions

%

96
103
31
39
47
31
31

43
37
7
14
6
1
14

45
36
22
36
13
3
45

Note: N = the number of participants who reported their conditions (out of 107).

Almost half (47%) of women said they were still experiencing menopausal
symptoms, with sleep disruption (26%), and hot flashes (24%) the most common, see
Table 5. Treatment for menopausal symptoms included hormone replacement therapy
(15%), nonhormonal/herbal (9%), and cannabis (15%). Half (50%) of participants said
they had a positive view about menopause, 18% had a negative view, and 32% were
neutral. The amount of time before falling asleep (M = 26.77) ranged from eight to 45
minutes, typical amount of sleep was less than eight hours (M = 6.91), and the number of
awakenings per night (M = 3.52, SD = 5.91) ranged from zero to nine.
Table 5. Participants experiencing menopausal symptoms
Symptom

N

%

Hot Flashes

37

24

Sleep Disturbance

41

26

Mood Changes

23

15

Night Sweats

25

16

Chills

6

4

Cognitive Issues (i.e., brain fog)

24

15

Note: Menopausal symptoms were reported by 49% of participants, N = 52.
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The responses about sexual health in Table 6 revealed that 43% of participants
were sexually active, 72% experienced orgasms, 61% reported a loss of interest in sex,
and 29% had concerns about their sex life.
Table 6. Sexual health and activity
Sexual Health
Currently Sexually Active
Pain with intercourse
Monogamous relationship
Concerns about sex life
Loss of interest in sexual activity
Loss of arousal
Loss of response, weaker or absent orgasm
Experiencing orgasm
Self-stimulated
With a partner
Both, self-stimulated and with partner
No orgasm

Yes
46
27
72
31
69
56
50
77
47
13
29

No
53
56
33
70
33
45
46
22

Prefer not to answer
8
17
2
6
5
6
11
8

18

Note: N = 107 responses.

Lifestyle choices showed that 50% of participants consumed alcohol, ranging
from two days per week (22%), to daily (16%), and 8% smoked more than six cigarettes
per day. Regular physical activity (exercising three to five times per week for 30 to 60
minutes each time) was reported by 71% of participants. See Table 7 for complete details.
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Table 7. Physical activity, intensity, and duration
Activity
Level of intensity
Low, (light yard/housework, slow walking)
Medium, (brisk walking, hiking, vacuuming)
High (jogging, running, treading water)
Duration of activity
5 to 25 minutes
30 to 55 minutes
60 minutes and above
Frequency
1 to 2 days per week
3 days per week
4 days per week
5 days per week
6 days per week
7 days per week

N

%

16
54
6

21
71
8

13
39
24

17
51
32

6
21
14
18
7
10

8
28
18
24
9
13

Note: N = 76, participants who reported regular physical activity

The indicators for MetS were analyzed as potential predictors of the QOL score
(M = 128.615), however the model summary did not show any significant associations
between MetS indicators and QOL score, (F = 1.457) and (p = 0.313). Correlations
showed a negative weak relationship between QOL satisfaction scores and waistline
circumference (-0.315), blood pressure (-0.197), HDL-C (-0.238), and fasting glucose
(-0.222). There was a negative moderate relationship between QOL scores and
triglycerides (-0.604). Significant positive correlations were found between QOL and
triglycerides (p = 0.014), waistline circumference and triglycerides (p = 0.005), waistline
and HDL-C (p = 0.002), and triglycerides and HDL-C (p = 0.009). Generally speaking,
there is a relationship between the presence of indicators for MetS and QOL scores in
postmenopausal women, and the alternative hypothesis is supported.
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Table 8. Regressions of associations between QOL scores and MetS risk indicators
Beta*

t

p-value

Triglycerides (>150mg/dL)

-.735

-1.913

.097

Fasting Glucose (>100mg/dL)

-.271

-.886

.405

Blood Pressure (>120/80mmHg)

-.186

-.609

.561

Waistline (>35 inches)

.114

.241

.816

HDL-C (<50mg/dL)

-.022

-.047

.964

MetS Risk Indicators

Note: R2 = 0.510. Dependent variable is the QOL score. *Standardized Beta Coefficients

Impacts of COVID-19

Responses to questions about the impact of social distancing and sheltering in
place due to the COVID-19 pandemic showed less satisfaction with QOL, an increase in
stressors, (i.e., income, health, isolation), changes to lifestyle, (i.e., less exercise,
increased alcohol), and more mental health issues (see Table 9).
Table 9. Impacts of COVID-19 restrictions

Changes
QOL satisfaction
Exercise frequency
Mental health issues
Stressors
Sexual health change
Time to fall asleep
Hours in bed
Hours of sleep
Early awakening/tired
Irregular sleep pattern
Alcohol consumption
Overall health change
Weight fluctuation
Caregiving change
Household changes
Housing situation
Income change
Occupation change
Employment change

More
%
7
18
30
73
6
21
13
13
19
23
15
7

Less
%
66
37
0
4
15
4
9
18
2
4
1
26

No Change
%
25
44
70
23
79
75
78
69
79
73
35
67

Yes
%

No
%

36
59
51
31
62
8
3
6
27
10
22

64
41
49
69
38
92
97
94
73
90
78
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DISCUSSION

In this study, we endeavored to investigate the relationship between satisfaction
with QOL and cardiometabolic risk factors during the postmenopausal phase. The model
summary did not show a significant association between MetS indicators and the QOL
satisfaction score, but there were significant positive correlations found between the
MetS indicators themselves, and between triglycerides and QOL. This could be
interpreted as women being able to find satisfaction with life in spite of the negative
physical outcomes related to MetS and menopause. These findings are consistent with
those of Vetter, et al (2011), who suggested that MetS in itself is not associated with
unsatisfactory QOL, but that other factors that may be involved.
Quality of Life Scores

The mean score of each QOL question, ranging from zero to ten, relates to the
domains of personal, social, income, and living environment. In the personal domain of
QOL satisfaction, participants rated their overall health, amount of walking, and
independence with a mean score of six, just above neutral. The mean score for purpose in
life, self-care, and food intake was eight. Participants’ scores showed that they are a little
satisfied with their personal lifestyle. Sexual satisfaction was also just above neutral, with
a mean score of six. This is consistent with questions about sexual health and the
percentage (53%) of women who are not sexually active, and expressed a loss of interest
(65%) in sexual activities.
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Social engagement scores were higher for questions about being understood, and
the amount of respect from others, both had a mean of nine or moderately satisfied.
Satisfaction with community involvement, help from and to family/friends had a mean
score of seven, a little satisfied. Seeing family and friends had a mean score of six, which
may be one of the effects of pandemic restrictions in place since March 2020.
There was a higher level of satisfaction (M = 8) with the way income met their
needs, and in regards to employment status (M = 8). This shows that participants were
moderately satisfied with their income and employment.
Sleep satisfaction score (M = 6) was low, and corresponds to the presence of
menopausal symptoms. Participants reported sleep disturbance (26%) and hot flashes
(24%) as the most disruptive to their sleep quality. They also slept less than eight hours
(M = 6.91) per night. Lack of sleep has been associated with increased menopausal
symptoms, obesity, mood problems, hypertension, and CVD risk, (Kim, et al, 2016).
Living environment responses revealed that adult children (7%), moved back
home due to loss of employment, and college residency pandemic restrictions. Some
participants (11%) had increased caregiving responsibilities, both in their own home, and
with a parent or sibling in an assisted living community. There were reports of home
maintenance issues, including pests/insects (14%), mold (14%), repairs needed (17%),
and problems with neighbors (6%). There were issues with their partner/spouse (7%); a
constant 24/7 presence, controlling behavior, and lack of support about menopause.
We asked what the major stressors were in their life, and allowed short answer
responses. The biggest source of stress (33%) was isolation, due to lack of contact with
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friends, family, and grandchildren while sheltering in place during the COVID-19
pandemic. Other stressors reported were finances (24%), uncertain job security (11%),
declining health (19%), disability (8%), and pain (6%). Women also said lack of exercise
options (6%), and weight gain (6%) contributed to their stress level, along with anxiety
(9%) about COVID-19 exposure. Depression (7%), and death in the family (6%) were
also listed as stressors. Menopausal symptoms (3%), contributed to stress about identity
due to hot flashes, and its effect on cosmetics.
Responses show that each domain of QOL was impacted, as well as overall
physical, mental and social well-being. Satisfaction levels ranged from a little unsatisfied
to somewhat satisfied in all 20 questions, including “how happy are you?” (M = 7.4).
Additional models are needed to determine the relationship between QOL scores and
sociodemographic data.
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CONCLUSION

Lifestyle modifications during the perimenopausal stage are necessary in order to
mitigate the physiological changes that increase CMD risk in the transition to menopause.
A program that includes aerobic exercise, strength training, mind-body therapies and
education about menopause is necessary to lower negative health outcomes, and reduce
the economic impact of associated healthcare costs in this population. Physical activities
provide some relief for vasomotor symptoms, sleep disruption, and mental issues (Taebi
et al., 2018). Strength training is needed to prevent muscle loss, pelvic floor atrophy,
osteoporosis, and a slower metabolism (Carr, 2003). Mind-body therapies such as yoga
and tai chi, have beneficial effects on mood, sleep, and reduce the risk for CMD (Innes, et
al, 2008). The majority of respondents (55%) said that they rarely have someone to talk
to about post-menopausal changes, and expressed interest in a program for support (27%)
during post-menopause, to improve their health (31%), and to improve their QOL (34%).
They would like the program to include physical activity (34%), mindful movement
(33%), dialogue (13%), and either virtual (32%), or in person (26%), when it is possible.
Being informed about what to expect during the transition to menopause gives a woman
the opportunity to modify her lifestyle for better health and QOL during postmenopause.
There were limitations to this research due to COVID-19 restrictions. Participants
self-reported their health history, current conditions, and physical characteristics. Not all
of the participants knew their blood pressure, lipid levels, or fasting glucose. The original
design of this study included laboratory blood analysis, and measurements of blood

32
pressure, waistline circumference, height and weight taken in person. Results may have
been more significant if there had been complete data across the participants. Future
research is needed to examine the relationships between QOL scores, socio-demographic
characteristics, and attitude about menopause for a more comprehensive analysis.
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APPENDIX

Quality of Life PM
Start of Block: Informed Consent

Informed Consent Quality of Life Post Menopause
Informed Consent Form: Principal Investigator
HSU Graduate Student
Chavela Riotutar, Kinesiology Master’s student, Humboldt State University
HSU Graduate Advisor
Dr. Taylor Bloedon, PhD, RDN, CSSD, Department of Kinesiology and Recreation Administration WHAT IS THE PURPOSE OF
THIS STUDY?
You are being invited to take part in a research study to assess the impact of Quality of Life (QOL) on cardiometabolic health. The
results will be used for a master’s thesis and will be published in a scientific journal. Menopause and its physiological changes
exacerbate a woman’s risk for developing obesity, insulin resistance, and hypertension, which are three of the five components of
Metabolic Syndrome (MetS). Both MetS and menopause have been associated with an unsatisfactory QOL that leads to negative
health outcomes. Identification and treatment of these indicators for MetS at an early stage gives the opportunity to prevent or
postpone diabetes and cardiovascular disease by making changes to daily lifestyle.
WHAT WILL OCCUR DURING THIS STUDY AND HOW LONG WILL IT LAST?
You are being asked to take part in a survey to assess the quality of your life and current health condition. You will also be asked
questions about changes due to COVID-19. This is in reference to the impact of sheltering in place and social distancing measures
instituted in mid to late March 2020. If you choose to participate in this study, you will begin by answering the health history
questionnaire, followed by completing the Quality-of-Life survey.
WHAT ARE THE BENEFITS OF THIS STUDY?
Potential benefits associated with the study include increased awareness of lifestyle risk factors, and identification of indicators for
metabolic syndrome obtained from the study’s data. Health screening information includes waistline circumference, blood lipid, blood
sugar, blood pressure, and other markers of metabolic health. General knowledge regarding the effect of quality of life on
cardiometabolic risk factors in postmenopausal women will be available in manuscript form after the study has ended.
WHAT ARE THE RISKS OF THIS STUDY?
The risks associated with this research are small, but possible due to the nature of the survey questions. A list of mental health support
organizations is included. If you should experience any of these discomforts, please be aware that you may contact the researchers for
assistance. Chavela Riotutar at 707-633-8453 or cld24@humboldt.edu, and Taylor Bloedon at 707-826-5967 or tkb95@humboldt.edu.
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WHO WILL SEE THE INFORMATION I GIVE?
Your confidentiality will be protected by assigning a unique identification number to you which will be used in place of your name on
data collected from the survey. When completing any of the questions in the study, you may omit items you prefer not to answer. To
ensure confidentiality, data will be collected from computer-based questionnaires using only the participant ID number. All electronic
files will be kept in the Qualtrics database, and data access will be strictly limited to key study personnel. Following data entry, hard
copy data will be destroyed within 3 years of final data analysis. The results of the study may be published in a scientific journal and
other types of publications. If you would like to see your final results, please contact Chavela Riotutar at cld24@humboldt.edu.
DO I HAVE A CHOICE TO BE IN THE STUDY?
Your participation in this study is entirely voluntary. You are not required to participate in this research, and you may stop your
participation at any time without penalty. You may skip any survey questions if you prefer not to answer.
CAN I BE DISMISSED FROM THE STUDY?
It is possible that research staff need to dismiss participants for variety of reasons. If there is a discrepancy in health assessment
results and/or survey responses and eligibility criteria, as approved by the HSU Institutional Review Board for Human Subjects,
research staff will need to dismiss the participant from the study.
WHAT IF I HAVE QUESTIONS?
If you have questions regarding this study or would like to be informed of the results when the study is completed, please feel free to
contact the researcher. Chavela Riotutar: cld24@humboldt.edu.
OTHER CONCERNS?
If you have any concerns with this study or questions about your rights as a participant, contact the Institutional Review Board for the
Protection of Human Subjects at irb@humboldt.edu or (707) 826-5165. If you agree to voluntarily participate in this research project
as described, please indicate your agreement by clicking the YES button below. We thank you for your participation in this research.

o
o

Yes, I consent to participating in this survey. (1)

No, I don't consent to participating in this survey. (2)

End of Block: Informed Consent
Start of Block: Inclusion Requirements
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Do you identify your sex as female since birth?

o
o

Yes (1)

No (2)

Are you older than 45 years of age?

o
o

Yes (1)

No (2)

Has it been at least one year since your last menstrual cycle?

o
o

Yes (1)

No (2)

End of Block: Inclusion Requirements
Start of Block: Demographics

Welcome to the Postmenopause Quality of Life Survey! This survey asks questions about your health, lifestyle, and the quality of your
life. You will also be asked questions about changes due to COVID-19. This is in reference to the impact of sheltering in place and
social distancing measures instituted in mid to late March 2020. It will take about 20 minutes to complete. There are no right or wrong
answers, please answer as honestly as you can. The survey can be completed on your mobile device, but you may have the best survey
response experience using a desktop or laptop computer. Please use the survey's navigation buttons below to go backward or forward
within the survey. Using your device or browser's navigation buttons might result in lost answers. Thank you for your participation in
this study!
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Age
45

51

56

62

67

73

78

84

89

95

100

0

5

10

15

20

25

30

35

40

45

50

What is your current age? ()

Menopausal Status

43
Approximately how many years has it been since your last
menstrual cycle? ()
Ethnicity: Select all that apply;

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

White (1)

Black or African American (2)

American Indian or Alaska Native (3)

Asian Indian (4)

Chinese (5)

Filipino (6)

Japanese (7)

Korean (8)

Vietnamese (9)

Guamanian or Chamorro (10)

Native Hawaiian or Pacific Islander (11)

Samoan (12)

Other (13)

I prefer not to answer (14)
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Are you of Hispanic or Latino origin?

▢
▢
▢
▢
▢

No, not Hispanic, Latino or Spanish origin (1)

Yes, Mexican, Mexican-American, Chicano (2)

Yes, Puerto Rican (3)

Yes, Cuban (4)

Yes, other Hispanic or Latino origin (5)

What is your employment status?

▢
▢
▢
▢
▢
▢

Working full-time (35 or more hours per week (1)

Working part-time (34 or fewer hours per week (2)

Looking for work (3)

Unemployed or laid off (4)

Retired (5)

Disabled (6)

As you complete the remainder of this survey there are questions about changes due to COVID-19. This is in reference to the impact
of sheltering in place and social distancing measures instituted in mid to late March 2020.
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Has your employment changed due to COVID-19?

o
o

Yes (1)

No (2)

Has your occupation changed due to COVID-19?

o
o

Yes (1)

No (2)

What was your total household income, before taxes and other deductions, during the past 12 months?

o
o
o
o
o
o
o
o
o

Less than $5000 (1)

$5,000 - $11,999 (2)

12,000 - $15,999 (3)

$16,000 - $24,999 (4)

$25,000 - $34,999 (5)

$35,000 - $49,999 (6)

$50,000 - $74,999 (7)

$75,000 - $99,999 (8)

$100,000 and greater (9)
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Has your income changed due to COVID-19?

o
o

Yes (1)

No (2)

What is the highest degree you have earned?

o
o
o
o
o
o
o

Less than high school (1)

High school graduate (2)

Some college (3)

2-year degree (4)

4-year degree (5)

Professional degree (6)

Doctorate (7)
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What is your current marital status?

o
o
o
o
o
o

Married (1)

Living with Partner (2)

Divorced (3)

Separated (4)

Widowed (5)

Never Married (6)

Do you?

o
o
o
o
o

Own your home? (1)

Rent your home? (2)

Live with a friend? (3)

Live with a relative? (4)

Other (5)

Has this recently changed due to COVID-19?

o
o

Yes (1)

No (2)
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Has your housing situation changed due to COVID-19?

o
o

Yes (1)

No (2)

In the past 12 months, how often were you not able to pay the mortgage or rent on time?

o
o
o
o
o

Always (1)

Most of the time (2)

About half the time (3)

Sometimes (4)

Never (5)

End of Block: Demographics
Start of Block: Living Environment

What is your housing situation today?

o
o
o
o

I have a steady place to live (1)

I have a place to live today, but I am worried about losing it in the future (2)

I do not have a steady place to live (e.g., temporarily staying with others, in a hotel, in a shelter, living on the
street, in a car, abandoned building, bus or train station) (3)

I prefer not to answer (4)
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Has this recently changed due to COVID-19?

o
o

Yes (1)

No (2)

Think about the place you live. Do you have problems with any of the following? Please check all that apply.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

pests such as bugs, ants, or mice (1)

mold (2)

lead paint or lead pipes (3)

lack of heat (4)

oven or stove not working (5)

smoke detectors missing or not working (6)

water leaks (7)

neighbor (8)

I prefer not to answer (9)

none of the above (10)

How many people are currently living in your household, including yourself?
0

3

6

9

12

15

18

21

24

27

30

50
()

Of the people living in your household, how many are over the age of 18, including yourself?
0

3

6

9

12

15

18

21

24

27

30

6

9

12

15

18

21

24

27

30

()

Of the people living in your household, how many are under the age of 18?
0

3

()

Has this recently changed due to COVID-19?

o
o

Yes (1)

No (2)

If yes, how has your household changed since COVID-19?

________________________________________________________________

51

Are you responsible for the care of someone else?

o
o

Yes (1)

No (2)

If yes, who are you responsible for? Check all that apply.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

spouse (1)

parent (2)

child (3)

grandchild (4)

sibling (5)

friend (6)

client (7)

partner (8)

other (9)

no one (10)
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Has this recently changed due to COVID-19?

o
o

Yes (1)

No (2)

If yes, have your caregiving responsibilities

o
o
o

increased (1)

decreased (2)

no change (3)

End of Block: Living Environment
Start of Block: Health History

Please answer the following questions about your health history as it would stand without any changes that may have occurred due to
COVID-19 as accurately and honestly as possible. All information obtained will remain confidential.

Weight
50

What is your current weight in pounds? ()

85

120

155

190

225

260

295

330

365

400
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How has your body weight changed with age?

o
o
o
o
o
o
o

significantly decreased (1)

moderately decreased (2)

slightly decreased (3)

slightly increased (4)

moderately increased (5)

significantly increased (6)

no change (7)

Height
40

44

20

38

49

53

58

62

66

71

75

80

84

110

128

146

164

182

200

What is your current height in inches? (for example, 5 feet
6 inches = 66 inches) ()

Waistline Circumference

What is the circumference of your waistline in inches,
measured at the belly button? ()

56

74

92

54

If you don't know the measurement of your waistline, please estimate the amount of your belly fat.

o
o
o

Large amount (1)

Medium amount (2)

Small amount (3)

Has your weight fluctuated (up or down) by more than 5 pounds in the past 6 months?

o
o

Yes (1)

No (2)

Are these changes due to COVID-19?

o
o

Yes (1)

No (2)

How would you rate your overall health at the present time?
Excellent (1)

Select one (1)

o

Good (2)

o

Average (3)

o

Poor (4)

o

Terrible (5)

o
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Has your overall health changed due to COVID-19?

o
o

Yes (1)

No (2)

If yes, please rate the change.

o
o
o

Better (1)

Worse (2)

No change (3)

Do you have a history of or are currently diagnosed with any Cardiovascular disorders? Please indicate:

▢
▢
▢
▢
▢
▢
▢

Heart attack (1)

Hypertension (high blood pressure) (2)

Hypotension (low blood pressure) (3)

Angina (4)

Shortness of breath (5)

Other (6)

None of the above (7)
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What is your blood pressure?

o
o
o
o
o

Low, less 90/60 (4)

Normal, less than 120/80 (5)

Elevated, 120-139/80-89 (6)

High, 140/90 (7)

I don't know (8)

Has your healthcare provider told you that your cholesterol was high or low?

o
o

Yes (1)

No (2)

What is your Total Cholesterol level?

o
o
o

less than 200 mg/dL (5)

more than 200 mg/dL (6)

I don't know (10)
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What is your LDL-C level? (bad cholesterol)

o
o
o

less than 100 mg/d (1)

more than 100 mg/d (2)

I don't know (3)

What is your HDL-C level? (good cholesterol)

o
o
o

more than 50 mg/dL (1)

less than 50 mg/dL (2)

I don't know (3)

What is your Triglyceride level?

o
o
o
o

less than 150 mg/dL (1)

150-300 mg/dL (2)

more than 300 mg/dL (3)

I don't know (4)
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Do you have a history of or are you currently diagnosed with any Metabolic/Endocrine disorders?

▢
▢
▢
▢
▢
▢

Type 1 Diabetes (1)

Type 2 Diabetes (2)

Hyperthyroid (overactive thyroid) (3)

Hypothyroid (underactive thyroid) (4)

Elevated Fasting Glucose (5)

None of the above (6)

Are you currently experiencing menopause symptoms?

o
o

Yes (1)

No (2)
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What type of menopause symptoms?

▢
▢
▢
▢
▢
▢
▢

Hot Flashes (1)

Sleep Disturbance (2)

Mood Changes (3)

Night Sweats (4)

Chills (5)

Cognitive Issues (i.e., brain fog) (7)

None of the above (8)

How do you treat your menopausal symptoms?

▢
▢
▢
▢

Hormone replacement therapy (1)

Nonhormonal/Complimentary herbal medicine (2)

Cannabis (3)

No treatment (4)
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Are you experiencing any of the following?

▢
▢
▢
▢
▢

Depression (1)

Substance abuse (2)

Cancer (3)

None of the above (4)

Other mental health issues (5)

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

Q168 Call 1-800-662-HELP (4357) if you need information about treatment. The Substance Abuse and Mental Health Service
Administration Helpline (SAMHSA) is a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in
English and Spanish) for individuals and families facing mental and/or substance use disorders.

End of Block: Health History
Start of Block: Lifestyle
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Do you drink beverages containing alcohol at least once per week?

o
o

Yes (1)

No (2)

Skip To: Q47 If Do you drink beverages containing alcohol at least once per week? = No

If yes, how many days per week do you drink alcoholic beverages?
▼1 (1) ... 7 (7)

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

Do you currently use tobacco?

o
o

Yes (1)

No (2)

Skip To: Q52 If Do you currently use tobacco? = No
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If yes, do you smoke cigarettes?

o
o

Yes (1)

No (2)

How many cigarettes do you smoke per day?

▼0 (1) ... more than 6 per day (8)

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

If yes, do you use e-cigarettes (vapor)?

o
o

Yes (1)

No (2)

How many e-cigarettes do you smoke per day?
▼0 (1) ... more than 6 per day (8)
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Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

Do you engage in any regular physical activity?

o
o

Yes (1)

No (2)

Skip To: Q56 If Do you engage in any regular physical activity? = No

If yes, what is the intensity?

o
o
o

Low (light yard/housework, slow walking, sitting at computer) (1)

Medium (brisk walking, bicycling, vacuuming, hiking) (2)

High (jogging/running, treading water) (3)

If yes, how many minutes per occasion?

▼5 (1) ... more than 60 minutes (13)

64
How many times per week do you exercise?

▼0 (1) ... more than 7 (9)

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

End of Block: Lifestyle
Start of Block: Sleep Pattern
Typical time to fall asleep?
1

How many minutes does it take to fall asleep? ()

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

7

13

19

25

31

36

42

48

54

60
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Typical Awakenings
0

6

12

18

24

30

36

42

48

54

60

1

3

6

8

10

13

15

17

19

22

24

1

3

6

8

10

13

15

17

19

22

24

How many times do you awaken per night? ()

Typical hours in bed?

How many hours of one day do you spend in bed? ()

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

Typical hours of sleep?

How many hours of one day do you sleep? ()

66

Is this more or less than before COVID-19?

o
o
o

More (1)

Less 2)

No change (3)

My sleep pattern is irregular.

o
o

Yes (1)

No (2)

Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

I awaken early in the morning still tired but unable to return to sleep.

o
o

Yes (1)

No (2)
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Is this more or less than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

End of Block: Sleep Pattern
Start of Block: QOL Satisfaction Measure

The next series of questions ask about your Quality of Life. When answering all of these questions please consider how you are
feeling right now. At the very end you will have the opportunity to indicate if your Quality of Life has changed due to the COVID-19
pandemic.

Please rate your responses to the questions with the following 11-point response scale:
0:

Extremely dissatisfied/unhappy

1 or 2:

Somewhat dissatisfied/unhappy

3 or 4:

A little dissatisfied/unhappy

5:

Neither satisfied/happy or dissatisfied/unhappy

6 or 7:

A little satisfied/happy

8 or 9:

Somewhat satisfied/happy

10:

Extremely satisfied/happy
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QOL1 How dissatisfied or satisfied are you with your physical health?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL2 How dissatisfied or satisfied are you with how well you care for yourself, for example, preparing meals, bathing, or shopping?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL3 How dissatisfied or satisfied are you with how well you think and remember?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o
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QOL4 How dissatisfied or satisfied are you with the amount of walking you do?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied

o o o o o o o o o o o

10 (1)

QOL5 How dissatisfied or satisfied are you with how often you get outside the house, for example, going into town, using public
transportation, or driving?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied

o o o o o o o o o o o

10 (1)

QOL6 How dissatisfied or satisfied are you with how well you carry on a conversation, for example, speaking clearly, hearing others,
or being understood?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o
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QOL7 How dissatisfied or satisfied are you with the kind and amount of food you eat?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL8 How dissatisfied or satisfied are you with how often you see or talk to your family and friends?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL9 How dissatisfied or satisfied are you with the help you get from your family and friends, for example, helping in an emergency,
fixing your house, or doing errands?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o
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QOL10 How dissatisfied or satisfied are you with the help you give to your family and friends?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied

o o o o o o o o o o o

10 (1)

QOL11 How dissatisfied or satisfied are you with your contribution to your community, for example, a neighborhood, religious,
political, or other group?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied

o o o o o o o o o o o

10 (1)

QOL12 How dissatisfied or satisfied are you with your work situation, for example, your current job, retirement for any reason, or
never having worked?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o
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QOL13 How dissatisfied or satisfied are you with the kind and amount of recreation or leisure you have?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL14 How dissatisfied or satisfied are you with your level of sexual activity or lack of sexual activity?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL15 How dissatisfied or satisfied are you with the way your income meets your needs?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o
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QOL16 How dissatisfied or satisfied are you with how respected you are by others?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL17 How dissatisfied or satisfied are you with the meaning and purpose of your life?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o

QOL18 How dissatisfied or satisfied are you with the amount of variety in your life?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied
10 (1)

o o o o o o o o o o o
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QOL19 How dissatisfied or satisfied are you with the amount and kind of sleep you get?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Dissatisfied
0: Satisfied

o o o o o o o o o o o

10 (1)

QOL20 How happy are you?
0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Unhappy
0: Very

o o o o o o o o o o o

Happy
10 (1)

Reflecting upon your responses, have the changes due to the COVID-19 pandemic increased or decreased the satisfaction with your
Quality of Life?

o
o
o

Yes, increased satisfaction with Quality of Life (28)

No, decreased satisfaction with Quality of Life (29)

No change (30)

End of Block: QOL Satisfaction Measure
Start of Block: Personal Habits and Social Engagement
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Please answer the following questions about your personal habits at the present time, as honestly as possible.

How often do you compare your body weight to health standards (e.g. BMI)?

o
o
o

Most of the time (1)

About half the time (2)

Rarely (3)

Is there someone available to whom you can count on to listen to you when you need to talk?

o
o
o

Most of the time (1)

About half the time (2)

Rarely (3)
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What is your relationship to the listener?

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

spouse (1)

partner (2)

friend (3)

sister (4)

brother (5)

parent (6)

doctor (7)

nurse (8)

therapist (9)

spiritual counselor (10)

support group (11)

other (12)

Is there someone available to you who shows you love and affection?

o
o
o

Most of the time (1)

About half the time (2)

Rarely (3)
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Is there someone you talk to about post-menopausal changes?

o
o
o

Most of the time (1)

About half the time (2)

Rarely (3)

What is your relationship to the listener?

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

spouse (1)

partner (2)

friend (3)

sister (4)

brother (5)

parent (6)

doctor (7)

nurse (8)

therapist (9)

spiritual counselor (10)

support group (11)

other (12)
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How do you view menopause?

o
o
o

Positively (no more periods or contraception) (1)

Negatively (loss of fertility and youth) (2)

Neutral (3)

Is there someone available to you who helps you make decisions about your health?

o
o
o

Most of the time (1)

About half the time (2)

Rarely (3)

Is there someone in your life who can support you in an exercise and diet program?

o
o
o

Most of the time (1)

About half the time (2)

Rarely (3)
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How important is family and friend support in managing your health issues?

o
o
o
o
o

Extremely important (1)

Very important (2)

Moderately important (3)

Slightly important (4)

Not at all important (5)

What are the current major stressors or changes in your life?

________________________________________________________________

Are there more or less stressors than before COVID-19?

o
o
o

More (1)

Less (2)

No change (3)

End of Block: Personal Habits and Social Engagement
Start of Block: Sexual Health

The next series of questions relate to your sexual health and activity at the present time. Please answer as honestly as possible.
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Q124 Are you currently sexually active? (not limited to sexual intercourse)

o
o
o

Yes (3)

No (5)

Prefer not to answer (4)

Q125 Do you have any pain with intercourse? (vaginal penetration)

o
o
o

Yes (3)

No (5)

Prefer not to answer (4)

Q126 If yes, how long ago did the pain start?

o
o
o
o
o

Recently (1)

1 year ago (2)

More than 1 year ago (3)

Never (4)

Prefer not to answer (5)
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Q127 Are you in a committed, mutually monogamous relationship?

o
o
o

Yes (3)

No (5)

Prefer not to answer (4)

Q128 How long have you been with your current sex partner(s)?

o
o
o
o
o
o

1 month or less (1)

1 to 12 months (2)

More than 1 year (3)

More than 10 years (4)

More than 20 years (5)

I don't have a sex partner (6)

Q129 Do you have concerns about your sex life?

o
o
o

Yes (3)

No (5)

Prefer not to answer (4)
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Q130 Do you have a loss of interest in sexual activities? (libido, desire)

o
o
o

Yes (3)

No (5)

Prefer not to answer (4)

Q131 Do you have a loss of arousal? (e.g., tingling in the genitals or breasts; vaginal moisture, warmth)

o
o
o

Yes (1)

No (2)

Prefer not to answer (3)

Q132 Do you have a loss of response? (weaker or absent orgasm)

o
o
o

Yes (1)

No (2)

Prefer not to answer (3)
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Q133 Do you currently experience orgasms?

o
o
o

Yes (3)

No (5)

Prefer not to answer (4)

Q134 If you do experience orgasms, are they?

o
o
o
o

Self-stimulated (1)

With a partner (2)

Both, with self and partner (3)

None (4)

Q166 Has your sexual health changed due to COVID-19?

o
o
o
o

Yes, improved (1)

Yes, declined (5)

No change (2)

Prefer not to answer (7)

End of Block: Sexual Health
Start of Block: Debrief
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Q152 Would you be interested in participating in a program that addresses any of the following?

▢
▢
▢
▢

Yes, to improve my Quality of Life (26)

Yes, to understand and improve my health (27)

Yes, for menopause support (29)

No (28)
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Q153 If a program becomes available and the COVID-19 pandemic is not an issue, what is your preference for program participation?
Please check all that apply.

▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢
▢

Weekly (1)

Monthly (2)

Indoor (3)

Outdoor (4)

Virtual (5)

In person (6)

Group Activities (7)

Individual Activities (8)

Group Dialogue (9)

Group Lead (10)

Instructor Lead (11)

Exercise/physical Activity (12)

Meditation/mindful movement (13)

Q154 When a program becomes available, may we contact you for participation?

o
o

Yes (1)

No (2)
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Q164 If yes, please enter your email address. In order to keep your responses anonymous, email addresses will be disassociated from
the rest of the survey data after the window closes.

________________________________________________________________

End of Block: Debrief

